NCT01925729View on ClinicalTrials.gov

TransMEM Gas Exchange -- Project 1, Aim 2

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

March 22, 2019

Study Completion Date

March 22, 2019

Conditions
Middle Ear DiseaseNasal Allergy
Interventions
BIOLOGICAL

ragweed

ragweed arm only

BIOLOGICAL

histamine

histamine arm only

DRUG

pseudoephedrine

pseudoephedrine arm only

DRUG

Oxymetazoline

oxymetazoline arm only

Trial Locations (1)

15213

Middle Ear Physiology Laboratory, University of PIttsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Cuneyt M. Alper

OTHER

NCT01925729 - TransMEM Gas Exchange -- Project 1, Aim 2 | Biotech Hunter | Biotech Hunter